CN111690606B - 体外激活扩增人体自然杀伤细胞及杀伤率检测方法 - Google Patents
体外激活扩增人体自然杀伤细胞及杀伤率检测方法 Download PDFInfo
- Publication number
- CN111690606B CN111690606B CN202010405488.1A CN202010405488A CN111690606B CN 111690606 B CN111690606 B CN 111690606B CN 202010405488 A CN202010405488 A CN 202010405488A CN 111690606 B CN111690606 B CN 111690606B
- Authority
- CN
- China
- Prior art keywords
- cells
- tube
- cell
- antibody
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/515—CD3, T-cell receptor complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010405488.1A CN111690606B (zh) | 2020-05-14 | 2020-05-14 | 体外激活扩增人体自然杀伤细胞及杀伤率检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010405488.1A CN111690606B (zh) | 2020-05-14 | 2020-05-14 | 体外激活扩增人体自然杀伤细胞及杀伤率检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111690606A CN111690606A (zh) | 2020-09-22 |
CN111690606B true CN111690606B (zh) | 2023-05-23 |
Family
ID=72477269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010405488.1A Active CN111690606B (zh) | 2020-05-14 | 2020-05-14 | 体外激活扩增人体自然杀伤细胞及杀伤率检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111690606B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113388042B (zh) * | 2021-06-28 | 2022-02-01 | 北京鼎成肽源生物技术有限公司 | 一种重组蛋白、重组表达载体、重组细胞和nk细胞激活磁珠及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103756963A (zh) * | 2012-12-13 | 2014-04-30 | 上海柯莱逊生物技术有限公司 | 一种体外扩增nk细胞的方法 |
CN105176926A (zh) * | 2015-09-22 | 2015-12-23 | 上海柯莱逊生物技术有限公司 | 一种体外培养扩增nk细胞的方法 |
CN105861435A (zh) * | 2016-05-11 | 2016-08-17 | 南京华奥生物医药技术有限公司 | 自然杀伤细胞的体外扩增方法 |
CN107326008A (zh) * | 2017-08-09 | 2017-11-07 | 上海莱馥医疗科技有限公司 | 一种从外周血中高效高纯度扩增自然杀伤细胞的方法 |
CN107904204A (zh) * | 2017-12-11 | 2018-04-13 | 领航干细胞再生医学工程有限公司 | 一种nk细胞的制备方法 |
-
2020
- 2020-05-14 CN CN202010405488.1A patent/CN111690606B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103756963A (zh) * | 2012-12-13 | 2014-04-30 | 上海柯莱逊生物技术有限公司 | 一种体外扩增nk细胞的方法 |
CN105176926A (zh) * | 2015-09-22 | 2015-12-23 | 上海柯莱逊生物技术有限公司 | 一种体外培养扩增nk细胞的方法 |
CN105861435A (zh) * | 2016-05-11 | 2016-08-17 | 南京华奥生物医药技术有限公司 | 自然杀伤细胞的体外扩增方法 |
CN107326008A (zh) * | 2017-08-09 | 2017-11-07 | 上海莱馥医疗科技有限公司 | 一种从外周血中高效高纯度扩增自然杀伤细胞的方法 |
CN107904204A (zh) * | 2017-12-11 | 2018-04-13 | 领航干细胞再生医学工程有限公司 | 一种nk细胞的制备方法 |
Non-Patent Citations (1)
Title |
---|
房良华.现代肿瘤免疫靶向治疗.《现代肿瘤免疫靶向治疗》.2010, * |
Also Published As
Publication number | Publication date |
---|---|
CN111690606A (zh) | 2020-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102268405B (zh) | 自体nk细胞体外活化扩增培养的方法及其专用培养基 | |
CN107326008A (zh) | 一种从外周血中高效高纯度扩增自然杀伤细胞的方法 | |
CN109666640A (zh) | 自然杀伤细胞体外纯培养的方法 | |
CN103756963A (zh) | 一种体外扩增nk细胞的方法 | |
CN107022524A (zh) | 一种从外周血单个核细胞中大量扩增nk细胞的方法 | |
CN108588022B (zh) | 体外培养富集人cd4+和cd8+ tcm细胞的方法 | |
CN108893443A (zh) | 一种细胞因子诱导脐带血自然杀伤细胞的高效扩增方法 | |
CN105925527A (zh) | 一种用于制备nk细胞的试剂盒及其应用方法 | |
Powell Jr et al. | Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program | |
CN113151168A (zh) | 一种人nk细胞培养体系及制备方法 | |
CN108251369B (zh) | 一种免疫细胞培养基、培养方法以及用途 | |
CN111500535B (zh) | 用于体外培养人自然杀伤细胞的方法和培养基 | |
CN111944754A (zh) | 一种自然杀伤细胞的培养方法 | |
CN111394308B (zh) | 一种脐带血淋巴细胞cik的培养方法 | |
WO2022194118A1 (zh) | 一种car-t细胞灌流培养方法 | |
CN111690606B (zh) | 体外激活扩增人体自然杀伤细胞及杀伤率检测方法 | |
TWI757709B (zh) | 含有nk細胞之細胞集團之製造方法 | |
WO2023216799A1 (zh) | 一种人nkt细胞系及其应用 | |
CN113249321A (zh) | 一种外周血nk细胞的培养方法 | |
CN115521914B (zh) | 一种人原代自然杀伤细胞体外扩增体系及方法 | |
Davison et al. | Monocyte derived dendritic cells have reduced expression of co-stimulatory molecules but are able to stimulate autologous T-cells in patients with MDS | |
CN108004210B (zh) | 一种大量诱导扩增具有adcc效应的nk细胞的方法 | |
Yokose et al. | Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes | |
CN113684180B (zh) | 一种提高骨髓瘤杀伤活性的nk细胞制备方法 | |
CN109486758A (zh) | 一种外周血nk细胞体外高效扩增试剂及操作说明 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210913 Address after: 215000 Room 102, building 3, Taihu new town science and Innovation Park, No. 18, Suzhou River Road, East Taihu Lake ecotourism Resort (Taihu new town), Wujiang District, Suzhou City, Jiangsu Province Applicant after: Suzhou Wujiang Houpu Biomedical Technology Co.,Ltd. Address before: Room 201-206, building A5, bio nano Park, 218 Xinghu street, industrial park, Suzhou, Jiangsu 215000 Applicant before: HOPE BIOLOGICAL TECHNOLOGY (SUZHOU) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
CB02 | Change of applicant information |
Address after: 215028 Room 201-202, A5 Building, Biological Nano Park, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China (Jiangsu) Pilot Free Trade Zone Applicant after: Suzhou Houpu Huikang Biomedical Technology Co.,Ltd. Address before: 215000 Room 102, building 3, Taihu new town science and Innovation Park, No. 18, Suzhou River Road, East Taihu Lake ecotourism Resort (Taihu new town), Wujiang District, Suzhou City, Jiangsu Province Applicant before: Suzhou Wujiang Houpu Biomedical Technology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |